GALNT2 expression is associated with glucose control and serum metabolites in patients with type 2 diabetes.

Vincenzo Trischitta Alessandra Antonucci Claudia Menzaghi Antonella Marucci Rosa Di Paola

Published in: Acta diabetologica (2024)

Our data indicate that in type 2 diabetes the expression of GALNT2 is associated with several serum metabolites. This association needs to be further investigated to understand in depth its role in mediating the effect of GALNT2 on insulin sensitivity, glucose control and other clinical features in people with diabetes.

Keyphrases

type diabetes
poor prognosis
glycemic control
ms ms
cardiovascular disease
blood glucose
binding protein
insulin resistance
optical coherence tomography
mass spectrometry
high resolution
adipose tissue
weight loss